4
Changes in Ownership
Prime Medicine, Inc. Filed Acc 0001628280-26-012893
Options or other derivatives
- Chief Executive Officer acquired 1,300,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Reine Allan Chief Executive Officer | 2026-02-26 | Grant or award · Stock Option (right to buy) | +1,300,000 | 1,300,000 | D | ||
Loading xslF345X05/wk-form4_1772229156.xml…